Most cases have been reported in patients with underlying inflammatory arthropathies. To our knowledge, there have been 10 reported cases of anti-TNF inhibitor-induced sarcoidosis in patients with inflammatory bowel disease, as summarized in Table 1 [8-16]. The gene discussed is TNF; the disease is sarcoidosis.